Viewing Study NCT02213250


Ignite Creation Date: 2025-12-24 @ 5:24 PM
Ignite Modification Date: 2026-04-02 @ 1:37 PM
Study NCT ID: NCT02213250
Status: COMPLETED
Last Update Posted: 2016-07-25
First Post: 2014-08-07
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: An Open-Label, Single Dose Pharmacokinetic Study of Benefix (Recombinant Factor IX) in Male Chinese Subjects With Hemophilia B
Sponsor: Pfizer
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-03
Start Date Type: None
Primary Completion Date: 2015-04
Primary Completion Date Type: ACTUAL
Completion Date: 2015-04
Completion Date Type: ACTUAL
First Submit Date: 2014-08-07
First Submit QC Date: None
Study First Post Date: 2014-08-11
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2016-05-04
Results First Submit QC Date: None
Results First Post Date: 2016-07-25
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2016-06-13
Last Update Post Date: 2016-07-25
Last Update Post Date Type: ESTIMATED